Skip to content

Change in AP at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$3.92B-84.4%
AbbVie logo
AbbVieABBV
-$1.59B-129%
Globus Medical logo
Globus MedicalGMED
$5.08M+665%
Solventum logo
SolventumSOLV
$23M+156%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-$21.4M-41.7%
Medtronic logo
MedtronicMDT
$123M-66.4%

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's change in AP?
Establishment Labs (ESTA) reported change in AP of -$2.58M in Q1 2026.
How has Establishment Labs's change in AP changed year-over-year?
Establishment Labs's change in AP decreased by 290.5% year-over-year, from $1.35M to -$2.58M.
What is the long-term trend for Establishment Labs's change in AP?
Over 2 years (2021 to 2024), Establishment Labs's change in AP has grown at a 16.0% compound annual growth rate (CAGR), from $4.96M to $6.67M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.